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Introduction
The MDR1 gene encodes P-glycoprotein (P-gp), a drug transporter that plays a great role
in drug disposition. P-gp is a component of the blood-brain barrier (prevents the CNS
from excessive exposition to toxic compounds) and also promotes drug excretion
through bile and urine.
Some individuals have a mutation in this gene, which can lead to potentially fatal
adverse drug reactions. This mutation has been mainly documented in herding dogs.
The genetic factor of a patient is one of the variables between animals that can
condition the result of an intervention. Thus, some individuals may require a different
anesthetic management.
Objectives
The aim of this bibliographic review is
to determinate the implications of the
MDR1 gene in the dogs anesthesia,
specifically hypnotics, analgesics and
other drugs that could be used in a
anesthetic protocol.
Moreover, it pretends to stablish a safe
protocol for the dogs that suffer from
this mutation of the MDR1 gene.
Conclusion
A safe anesthetic protocol for dogs with the mutation of
MDR1 consists in a 50% reduction of the normal dose with
the drugs involved, specially morphine, butorphanol,
buprenorphine and acepromazine. Another option is
choosing drugs that are not substrates of the P-gp instead,
for example, NSAIDs for the analgesia and α2-adrenergic
agonists (dexmedetomidine).
Affected breeds
The main affected breeds are
Collies (Rough and Smooth),
Shetland Sheepdog, Australian
Shepherd, Miniature Australian
Shepherd, Longhaired Whippet,
Silken Windhound, Border Collie,
Wäller, German Shepherd, English
Shepherd, McNab and Bobtail.
* Breeds in bold are the ones with
more incidence of the mutation.
Despite this, the popular belief
among the veterinarians is that
Border Collie is one of the main
affected breeds: white feet don’t
treat.
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Drugs involved
Drug P-gp substrate MDR1 mutated
dogs affected
Morphine
Methadone
Butorphanol
Buprenorphine
Fentanyl
Acepromazine
Midazolam
Lidocaina
Vercuronium
bromide
